Abstract
Bipolar disorder (BD), a chronic mental illness of mood disturbances, can affect persons of any age. Because BD is a disease with frequent relapses and incomplete remissions, it is challenging to manage. Over the last several years, a number of new psychopharmacologic and therapeutic tools have been developed to help attain the goal of sustained, full remission for patients. Here we review the current data on the course of BD across the life cycle and make management recommendations for achieving and maintaining complete remission without residual symptoms of BD, when possible.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 36-38+41 |
| Journal | Drug Benefit Trends |
| Volume | 16 |
| Issue number | 1 |
| State | Published - Jan 2004 |
| Externally published | Yes |
Fingerprint
Keywords
- Bipolar disorder
- Depression
- Relapse
- Remission
ASJC Scopus subject areas
- Pharmaceutical Science
- Leadership and Management
Cite this
Managing bipolar disorders with the goal of achieving remission. / Hah, Mina; Chang, Kiki.
In: Drug Benefit Trends, Vol. 16, No. 1, 01.2004, p. 36-38+41.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Managing bipolar disorders with the goal of achieving remission
AU - Hah, Mina
AU - Chang, Kiki
PY - 2004/1
Y1 - 2004/1
N2 - Bipolar disorder (BD), a chronic mental illness of mood disturbances, can affect persons of any age. Because BD is a disease with frequent relapses and incomplete remissions, it is challenging to manage. Over the last several years, a number of new psychopharmacologic and therapeutic tools have been developed to help attain the goal of sustained, full remission for patients. Here we review the current data on the course of BD across the life cycle and make management recommendations for achieving and maintaining complete remission without residual symptoms of BD, when possible.
AB - Bipolar disorder (BD), a chronic mental illness of mood disturbances, can affect persons of any age. Because BD is a disease with frequent relapses and incomplete remissions, it is challenging to manage. Over the last several years, a number of new psychopharmacologic and therapeutic tools have been developed to help attain the goal of sustained, full remission for patients. Here we review the current data on the course of BD across the life cycle and make management recommendations for achieving and maintaining complete remission without residual symptoms of BD, when possible.
KW - Bipolar disorder
KW - Depression
KW - Relapse
KW - Remission
UR - http://www.scopus.com/inward/record.url?scp=0442278346&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0442278346&partnerID=8YFLogxK
M3 - Article
VL - 16
SP - 36-38+41
JO - Drug Benefit Trends
JF - Drug Benefit Trends
SN - 1080-5826
IS - 1
ER -